Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 3
2000 3
2001 4
2002 5
2003 7
2004 2
2005 1
2006 7
2007 5
2008 4
2009 2
2010 7
2011 9
2012 5
2013 1
2014 5
2015 8
2016 12
2017 7
2018 4
2019 8
2020 11
2021 12
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Elevated mortality after successful tuberculosis treatment.
van den Hof S, Borgdorff MW. van den Hof S, et al. Int J Tuberc Lung Dis. 2016 Jan;20(1):2. doi: 10.5588/ijtld.15.0652. Int J Tuberc Lung Dis. 2016. PMID: 26688521 Free PMC article. No abstract available.
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences.
Tiemersma E, van den Hof S, Dravniece G, Wares F, Molla Y, Permata Y, Lukitosari E, Quelapio M, Aung ST, Aung KM, Thuy HT, Hoa VD, Sulaimanova M, Sagyndikova S, Makhmudova M, Soliev A, Kimerling M. Tiemersma E, et al. Among authors: van den hof s. Eur Respir Rev. 2019 Oct 11;28(153):180115. doi: 10.1183/16000617.0115-2018. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31604816 Free article. Review.
Evidence-based interventions to reduce tuberculosis stigma: a systematic review.
Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A. Sommerland N, et al. Among authors: van den hof s. Int J Tuberc Lung Dis. 2017 Nov 1;21(11):81-86. doi: 10.5588/ijtld.16.0788. Int J Tuberc Lung Dis. 2017. PMID: 29025489 Review.
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F; RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative). Mitnick CD, et al. Among authors: van den hof s. PLoS One. 2016 May 25;11(5):e0155968. doi: 10.1371/journal.pone.0155968. eCollection 2016. PLoS One. 2016. PMID: 27223622 Free PMC article. Review.
[No scientific lower threshold for compulsory vaccination].
Klinkenberg D, Veldhuijzen IK, Ruijs WLM, de Melker HE, Wallinga J, van den Hof S, van Dissel JT, van Vliet JA. Klinkenberg D, et al. Among authors: van den hof s. Ned Tijdschr Geneeskd. 2020 May 7;164:D4556. Ned Tijdschr Geneeskd. 2020. PMID: 32395948 Dutch.
Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
Knol MJ, Backer JA, de Melker HE, van den Hof S, Gier B. Knol MJ, et al. Among authors: van den hof s. Lancet Infect Dis. 2022 Jan;22(1):16-17. doi: 10.1016/S1473-3099(21)00763-5. Lancet Infect Dis. 2022. PMID: 34953541 Free PMC article. No abstract available.
[The role of children in the transmission of SARS-CoV-2].
van der Hoek W, Backer JA, Bodewes R, Friesema I, Meijer A, Pijnacker R, Reukers DFM, Reusken C, Roof I, Rots N, Te Wierik MJM, van Gageldonk-Lafeber AB, Waegemaekers CHFM, van den Hof S. van der Hoek W, et al. Among authors: van den hof s. Ned Tijdschr Geneeskd. 2020 Jun 3;164:D5140. Ned Tijdschr Geneeskd. 2020. PMID: 32749807 Dutch.
131 results